Bio­gen chair Ste­lios Pa­padopou­los takes his in­vest­ing ex­pe­ri­ence to the SPAC par­ty, rais­ing $100M for a blank check deal

A long­time biotech vet — and one of the best con­nect­ed ex­ecs in the in­dus­try — is jump­ing in­to the SPAC game, en­ter­ing the play­ing field with $100 mil­lion in the blank check com­pa­ny.

Ste­lios Pa­padopou­los, the chair­man of Bio­gen since 2014, closed the $100 mil­lion raise Fri­day as he seeks a biotech part­ner to go pub­lic through a re­verse merg­er. The SPAC, called Eu­crates Bio­med­ical Ac­qui­si­tion, priced at $10 per share and each share comes with one-third of a war­rant that can be used to buy shares at $11.50 each.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER